Xiangtan Electrochemical Scientific (002125.SZ) plans to launch a 2026 restricted stock incentive plan.
Xiangtan Electrochemical Scientific (002125.SZ) disclosed a 2026 restricted stock incentive plan (draft), proposing to grant a total of 8.8935 million restricted shares to incentive recipients, accounting for approximately 1.41% of the company's total share capital at the time of the announcement of this incentive plan. This incentive plan is proposed to be granted in a single tranche, with no reserved equity. The total number of proposed incentive recipients is 158, and the grant price is 6.26 yuan per share.
Xiangtan Electrochemical Scientific (002125.SZ) disclosed the draft of its 2026 restricted stock incentive plan. The total number of restricted shares proposed to be granted to incentive recipients is 8.8935 million shares, accounting for approximately 1.41% of the company's total share capital at the time of the announcement of this incentive plan. This incentive plan is proposed to be granted in a single tranche, with no reserved equity. The total number of proposed incentive recipients is 158, and the grant price is 6.26 yuan per share.
Related Articles
AI infrastructure supplier Accelevation (ACCV.US) races toward U.S. IPO, valued at up to $5.37 billion.
SF INTRA-CITY (09699) repurchased 896,000 shares for HK$7.9905 million on September 22.
Changchun High-Tech Industry (000661.SZ): Clinical trial application for the recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination product has been accepted.
AI infrastructure supplier Accelevation (ACCV.US) races toward U.S. IPO, valued at up to $5.37 billion.
SF INTRA-CITY (09699) repurchased 896,000 shares for HK$7.9905 million on September 22.
Changchun High-Tech Industry (000661.SZ): Clinical trial application for the recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination product has been accepted.
